News
-
-
-
PRESS RELEASE
BIOVERSYS ANNOUNCES INTENTION TO FLOAT ON THE SIX SWISS EXCHANGE
BioVersys AG announces intention to float on SIX Swiss Exchange, targeting primary-only proceeds of approx. CHF 80 million to advance lead asset BV100 through Phase 3 and finance operating expenses. IPO supported by AMR Action Fund and GSK